Target intelligence / Profile preview

Terminal differentiation-induced non-coding RNA (TINCR)

Target
TINCR
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Other
01

Overview

TINCR (Terminal differentiation-induced non-coding RNA) is a long intergenic non-coding RNA (lincRNA), specifically classified as a lncRNA, implicated primarily in the regulation of epidermal differentiation and tissue development[1][2]. Unlike classical protein-coding targets, TINCR exerts its function at the RNA level: it acts as a scaffold for RNA-binding proteins, such as Staufen1, and promotes the post-transcriptional stabilization and accumulation of mRNAs needed for epidermal differentiation, predominantly by interacting with the TINCR box motif on target mRNAs[1]. TINCR does not encode a functional receptor, enzyme, or protein target; instead, it operates as an RNA molecule regulating gene expression and cell fate via epigenetic and post-transcriptional mechanisms. Dysregulation or altered expression of TINCR has been reported in certain cancers and may serve as a tissue-specific biomarker[2][3]. There is currently no evidence of direct drug interaction or targeting of TINCR, and its mechanism represents RNA-based scaffolding and regulatory functions rather than conventional "therapeutic target" activity[1][2]. **Essential context:** - TINCR is not a protein, receptor, kinase, transporter, or enzyme but a non-coding RNA[1][2]. - Its most widely accepted role is in skin/epidermal biology, specifically driving terminal differentiation by stabilizing differentiation-aiding mRNAs in the cytoplasm[1]. - Although associated with cancer biology in some studies, it is not directly targeted by drugs nor is it established as a validated clinical target. - Aliases like "TINCR ubiquitin domain containing" and "TINCR-encoded ubiquitin-like protein" are misleading, as TINCR’s function is as a non-coding RNA, not a ubiquitin-like protein. - TINCR is best referred to using its canonical lncRNA designation, and not as a protein target. **Limitations:** - No direct pharmacology, mechanism of action for drugs, or established safety concerns have been reported. - May be considered as a biomarker in some tissues or cancers but is not a clinical therapeutic target at present.

Other names
Ubiquitin domain-containing protein TINCRLINC00036NCRNA00036FLJ90734onco-lncRNA-16TUBLPlacenta-specific protein 2PLAC2TINCR-encoded ubiquitin-like proteinlong intergenic non-protein coding RNA 36terminal differentiation-induced ncRNAtissue differentiation-inducing non-protein coding RNA
02

Biological functions

Regulation of mRNA stabilityPromotion of epidermal differentiationScaffolding of RNA-binding proteinsPost-transcriptional gene regulation
03

Disease associations

CancerOther (involvement in epithelial biology and tissue differentiation)
04

Biomarkers

Biomarker for epidermal differentiation (potential)Biomarker for certain cancer phenotypes (potential)

Beyond the preview

Go deeper on Terminal differentiation-induced non-coding RNA (TINCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Terminal differentiation-induced non-coding RNA (TINCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call